Examiner Profile: OGUNBIYI, OLUWATOSIN A - Patent Office Action Stats

Examiner: OGUNBIYI, OLUWATOSIN A

Tech Center 1700 • Art Units: 1641 1645 1733

This examiner grants 64% of resolved cases

Performance Statistics

63.7%

Allow Rate

-1.3% vs TC avg

981

Total Applications

+41.5%

Interview Lift

1061

Avg Prosecution Days

Based on 930 resolved cases, 2023–2026

6.2%

§101 Eligibility

21.3%

§102 Novelty

28.3%

§103 Obviousness

29.8%

§112 Clarity

App #	Title	Status	Assignee
18711074	TREATMENT OF PAIN	Non-Final OA	IPSEN BIOPHARM LIMITED
18826093	INJECTABLE HYDROGEL FOR SUSTAINED CO-DELIVERY OF AN ANTIGEN AND AN ADJUVANT, AND USES THEREOF	Non-Final OA	The Regents of the University of California
18704758	DESIGNER EXTRACELLULAR VESICLES FOR TARGETED DELIVERY TO SCHWANN CELLS	Non-Final OA	Ohio State Innovation Foundation
18697325	ENGINEERED VECTORS AND ORGANISMS CONTAINING THE SAME FOR ISOFLAVONE CONVERSION IN THE GUT	Non-Final OA	Board of Regents, The University of Texas System
18863566	IMMUNOBIOTICS FOR PREVENTING BACTERIAL PNEUMONIA AND METHODS OF USING THE SAME	Non-Final OA	The Regents of the University of Colorado, A Body Corporate
17434349	TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM	Final Rejection	The General Hospital Corporation

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.